Publications by authors named "L E Norwood-Toro"

Telomerase reverse transcriptase (TERT) (catalytic subunit of telomerase) is linked to the development of coronary artery disease (CAD); however, whether the role of nuclear vs. mitchondrial actions of TERT is involved is not determined. Dominant-negative TERT splice variants contribute to decreased mitochondrial integrity and promote elevated reactive oxygen species production.

View Article and Find Full Text PDF

Ventilation with gases containing enhanced fractions of oxygen is the cornerstone of therapy for patients with hypoxia and acute respiratory distress syndrome. Yet, hyperoxia treatment increases free reactive oxygen species (ROS)-induced lung injury, which is reported to disrupt autophagy/mitophagy. Altered extranuclear activity of the catalytic subunit of telomerase, telomerase reverse transcriptase (TERT), plays a protective role in ROS injury and autophagy in the systemic and coronary endothelium.

View Article and Find Full Text PDF

Chemotherapy (CT) is a necessary treatment to prevent the growth and survival of cancer cells. However, CT has a well-established adverse impact on the cardiovascular (CV) system, even years after cessation of treatment. The effects of CT drugs on tumor vasculature have been the focus of much research, but little evidence exists showing the effects on the host microcirculation.

View Article and Find Full Text PDF
Article Synopsis
  • Elevated levels of mitochondrial reactive oxygen species (ROS) are linked to cardiovascular diseases, with TERT playing a crucial role in reducing ROS and enhancing ATP production.
  • A study using a TERT-deficient rat model revealed no baseline structural changes in cardiac function; however, TERT rats showed reduced coronary flow and elevated left ventricle pressure after ischemia/reperfusion injury.
  • Despite these issues, TERT rats had smaller infarct sizes compared to wild-type rats, indicating that the lack of TERT activity increases vulnerability to cardiac stress.
View Article and Find Full Text PDF

Nonmuscle myosin-IIA (NMHC-IIA) heavy chain phosphorylation has gained recognition as an important feature of myosin-II regulation. In previous work, we showed that phosphorylation on S1943 promotes myosin-IIA filament disassembly in vitro and enhances EGF-stimulated lamellipod extension of breast tumor cells. However, the contribution of NMHC-IIA S1943 phosphorylation to the modulation of invasive cellular behavior and metastasis has not been examined.

View Article and Find Full Text PDF